National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

anti-VEGFR monoclonal antibody (AN-tee … MAH-noh-KLOH-nul AN-tee-BAH-dee)

 A monoclonal antibody being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Anti-VEGFR monoclonal antibodies bind to receptors for vascular endothelial growth factor (VEGF) and keeps VEGF from binding to them. This may stop the growth of new blood vessels that tumors need to grow. It is a type of antiangiogenesis agent.



Previous Definitions:anti-idiotype vaccine, anti-IL-6 chimeric monoclonal antibody, anti-inflammatory, anti-mesothelin monoclonal antibody MORAb-009, anti-TGF-beta monoclonal antibody GC1008
Next Definitions:antiandrogen, antiandrogen therapy, antiangiogenesis, antiangiogenic, antiapoptotic

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov